摘要Neural progenitor cells(NPCs)capable of self-renewal and differentiation into neural cell lineages offer broad prospects for cell therapy for neurodegenerative diseases.However,cell therapy based on NPC transplantation is limited by the inability to acquire sufficient quantities of NPCs.Previous studies have found that a chemical cocktail of valproic acid,CHIR99021,and Repsox(VCR)promotes mouse fibroblasts to differentiate into NPCs under hypoxic conditions.Therefore,we used VCR(0.5 mM valproic acid,3 μM CHIR99021,and 1 uM Repsox)to induce the reprogramming of rat embryonic fibroblasts into NPCs under a hypoxic condition(5％).These NPCs exhibited typical neurosphere-like structures that can express NPC markers,such as Nestin,SRY-box transcription factor 2,and paired box 6(Pax6),and could also differentiate into multiple types of functional neurons and astrocytes in vitro.They had similar gene expression profiles to those of rat brain-derived neural stem cells.Subsequently,the chemically-induced NPCs(ciNPCs)were stereotactically transplanted into the substantia nigra of 6-hydroxydopamine-lesioned parkinsonian rats.We found that the ciNPCs exhibited long-term survival,migrated long distances,and differentiated into multiple types of functional neurons and glial cells in vivo.Moreover,the parkinsonian behavioral defects of the parkinsonian model rats grafted with ciNPCs showed remarkable functional recovery.These findings suggest that rat fibroblasts can be directly transformed into NPCs using a chemical cocktail of VCR without introducing exogenous factors,which may be an attractive donor material for transplantation therapy for Parkinson's disease.